Back to Agendas
[V4-S3] The Next Generation Drug Development for Personalized Health Care
Session Chair(s)
Hideharu Yamamoto, PhD
Biostatistics Deputy Dept Manage, Biometrics Dept
Chugai Pharmaceutical Co., Ltd., Japan
All medicines, both on the market and under research/development, can be precision medicine, when the adequate usage information for each individual is enhanced. Recently, supplying the information for the personalization of medical products has become a duty of the pharmaceutical industry. So far, most pharmaceutical companies’ commitments to such activities have not resulted in much progress. In this session, we will introduce a research outcome of approved precision medicines in Japan and discuss novel drug development strategy with clinical study design that fits in with today’s society.
Speaker(s)
Applied Drug Development for Personalized Medicine
Shinichi Tsuchiwata, MS
Pfizer R&D Japan G.K., Japan
Manager, Clinical Pharmacology
Gene Finding for Patient Selection in Academic Researches
Akihiro Hirakawa, PhD
Tokyo Medical and Dental University, Japan
Professor,Clinical Biostatistics,Graduate School of Medical and Dental Sciences
Recent Advances in Clinical Trial Design for Personalized Medicine – Regulatory Perspective
Hiroyuki Sato, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of New Drug V
Have an account?